Showing results 10 to 16 of 16
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Responses to peginterferon alfa-2a (40KD) (PEGASYS) treatment are durable in Asian Patients with HBeAg-Negative CHB: 12 month Follow-Up Data from a large Randomised Study Proceeding/Conference:Journal of Gastroenterology and Hepatology | 2006 | ||
Telbivudine (LdT) vs. lmivudine for chronic Hepatitis B: First-year results from the international phase III GLOBE trial Proceeding/Conference:Hepatology | 2005 | ||
Telbivudine displays consistent antiviral efficacy across patient subgroups for the treatment of chronic hepatitis B: Results from the GLOBE study Proceeding/Conference:Journal of Hepatology | 2006 | ||
2006 | |||
Telbivudine versus lamivudine in patients with chronic hepatitis B Journal:New England Journal of Medicine | 2007 | ||
Telbivudine vs Lamivudine in HBeAg-Positive Patients with CHB: Two-Year Efficacy and Predictors of Response Proceeding/Conference:Hepatology International | 2007 | ||
2006 |